ArticleJournal of diabetes investigation2019

Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.

Yukishige Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.